2023. A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. One Health & Risk Management . 4, 4 (Sep. 2023), 19–26. DOI:https://doi.org/10.38045/ohrm.2023.4.02.